<DOC>
	<DOCNO>NCT01472068</DOCNO>
	<brief_summary>This pilot clinical study take place one site Berlin , Germany use Neuromuscular Electrical Stimulation ( NMES ) stimulate pelvic floor muscle 20 woman suffer stress urinary incontinence . This involve 12 week , 30 minute , 5 day 7 set treatment program device . After 12 week treatment programme subject ask perform daily set exercise 14 week .</brief_summary>
	<brief_title>A Pilot Study Evaluate Safety Performance Neuromuscular Electrical Stimulation With Inko RS Device Treatment Stress Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Subjects female least 18 year age . Subject sign informed consent form prior study related activity Subjects previously fail 6 week volitional pelvic floor muscle train program . Subjects clinically diagnosed stress urinary incontinence demonstrate &gt; 4g urine leakage follow standardise 1minute stress test 1 hour postbladder fill protocol ( 1hour pad weight test ) . Stress urinary incontinence define complaint involuntary leakage effort exertion , sneeze cough ' ( International Continence Society ) . Subjects score least 18 27 Stress Incontinence Questions confirm predominant stress urinary incontinence Medical , Epidemiologic Social Aspects Aging Urinary Incontinence ( MESA ) Questionnaire complete screen assessment . Subjects Body Mass Index &lt; 30 kg/m2 Subjects able give voluntary , write informed consent participate study consent obtain . Subjects able understand study willing complete study assessment . Subjects exist medical condition would compromise participation study . Subjects physical condition would make unable perform study procedure . Subjects history respiratory condition include chronic cough . Subjects history underlie neurological condition . Subjects history low back pain involve spinal nerve root . Subject currently take medication , take medication last 4 week , urinary incontinence effect urinary output function include anticholinergic antihistamine antianxiety medication . Subjects blood clot disorder take anticoagulant medication . Subjects previously urogynaecological relate surgery exclude hysterectomy . Subjects clinical diagnosis prolapse great Stage 2 . Subjects pregnant could pregnant . Subjects le 6 month postpartum lactate . Subjects intrauterine device metal implant pelvic area , include hip lumbar spine . Subjects pelvic pain fibromyalgia paravaginal defect . Subjects active implanted medical device ( ie pacemaker , pump etc ) . Subjects history heart disease stroke . Subjects know cancer . Subjects injury disability affect part body contact garment . Subjects currently involved injury litigation claim . Subjects participate clinical study last 3 month . Any vulnerable subject define individual whose willingness volunteer clinical study may unduly influenced expectation , whether justify , benefit associate participation , retaliatory response senior member hierarchy case refusal participate . Examples member group hierarchical structure , medical , pharmacy , dental , nursing student , subordinate hospital laboratory personnel , employee pharmaceutical medical device industry , member arm force , person keep detention . Other vulnerable subject include patient incurable disease , person nurse home , unemployed impoverished person , patient emergency situation , ethnic minority group , homeless person , nomad , refugee , minor , incapable give consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Incontinence</keyword>
	<keyword>NMES</keyword>
</DOC>